Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
This small, double-blind pilot trial gave 28 people with alcohol problems either a sublingual esketamine film (115.1 mg) or a vitamin C placebo while they did two weeks of daily mindfulness practice. Compared with placebo, esketamine increased people’s psychological engagement with the meditation, produced stronger mystical and dissociative experiences, and…